ITT

First MDS consortium to conduct trials and research to improve patient outcomes

Thursday, June 14, 2012 09:23 AM

Taussig Cancer Institute at Cleveland Clinic will participate in an unprecedented, six-institution consortium designed to conduct clinical trials and research to improve outcomes for patients with myelodysplastic syndrome (MDS).

More... »

Modulation Therapeutics receives $500,000 from MMRF for cancer treatment

Monday, June 11, 2012 11:54 AM

The Multiple Myeloma Research Foundation (MMRF) has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics, an early-stage pharmaceutical company which has licensed MTI-101 from the Moffitt Cancer Center.

More... »

Nitto Denko acquires all assets of Altea Therapeutics

Thursday, May 17, 2012 09:39 AM

Nitto Denko, a Japanese materials manufacturer, has acquired all the assets of Altea Therapeutics, a creator of transdermal drug delivery systems.

More... »

Newly patented trial-patient pairing system promises to accelerate cancer trials

Wednesday, February 15, 2012 03:38 PM

A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial.

More... »

Cetero Research expands senior management team

Tuesday, December 27, 2011 11:49 AM

Cetero Research has reported two new appointments to its senior management team. Michael C. Fillios was named chief administrative officer, with leadership responsibility and oversight of human resources, information technology, project management, marketing and client services. David Coggin was named vice president, biometrics. He will oversee the operational management of PK/PD, data management, miostatistics and medical writing services.

More... »

Axia Value names Christina managing director

Wednesday, November 2, 2011 01:03 PM

More... »

Moffitt, The US Oncology Network advance cancer patient services

Thursday, October 27, 2011 12:57 PM

Moffitt Cancer Center,  the only National Cancer Institute(NCI) Comprehensive Cancer Center in Florida, and The US Oncology Network will work together to expand access to patient services in Florida. As part of both organizations’ long-term commitment to advancing the quality and science of cancer care, the two are collaborating to develop and operate community-based cancer centers throughout the state.

More... »

Biotron’s phase IIa Hepatitis C study shows positive results

Tuesday, October 11, 2011 12:29 PM

Australian drug development company Biotron has released results from its phase IIa trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients.

More... »

AcelRx names Edwards to board of directors

Wednesday, September 28, 2011 11:55 AM

AcelRx Pharmaceuticals has named Mark G. Edwards to its board of directors. Edwards will also serve as the chairman of the audit committee.

More... »

Rebecca Kush to serve on HITS Standards Committee

Wednesday, July 20, 2011 11:48 AM

Rebecca Daniels Kush has been invited to serve on the HIT Standards Committee, a federal advisory committee that makes recommendations to the national coordinator on standards, implementation specifications and certification criteria for the electronic exchange and use of health information for the purposes of adoption, consistent with the implementation of the Federal Health IT Strategic Plan, and in accordance with policies developed by the HIT Policy Committee.

More... »